{"log_id": 5621791987737263871, "direction": 0, "words_result_num": 47, "words_result": [{"probability": {"variance": 0.011386, "average": 0.952969, "min": 0.545532}, "location": {"width": 544, "top": 144, "height": 39, "left": 226}, "words": "部分患者在8周时具有 RECIST定义的完全级解,部分缓解及疾病稳定"}, {"probability": {"variance": 0.004491, "average": 0.977708, "min": 0.566929}, "location": {"width": 911, "top": 193, "height": 57, "left": 213}, "words": "图1研究A8081001中根据研究者对ALK阳性非小细胞肺癌患者的评估,患者目标病灶相对基线最佳百分"}, {"probability": {"variance": 0.000116, "average": 0.994069, "min": 0.970076}, "location": {"width": 121, "top": 223, "height": 29, "left": 213}, "words": "变化的瀑布图"}, {"probability": {"variance": 4e-06, "average": 0.998599, "min": 0.993775}, "location": {"width": 24, "top": 352, "height": 149, "left": 217}, "words": "基线下降或增加值"}, {"probability": {"variance": 0.007537, "average": 0.966961, "min": 0.6352}, "location": {"width": 264, "top": 673, "height": 32, "left": 202}, "words": "来源:60天临床补充数据图14.4"}, {"probability": {"variance": 0.058611, "average": 0.516339, "min": 0.251482}, "location": {"width": 185, "top": 661, "height": 25, "left": 541}, "words": " BOR PD USD PR"}, {"probability": {"variance": 0.011114, "average": 0.955137, "min": 0.388784}, "location": {"width": 914, "top": 695, "height": 55, "left": 202}, "words": "缩写:BOR=总体最佳缓解:PD=疾病进展;SD=疾病稳定;PR部分缓解;CR=完全缓解;N=患者数;ALK=间"}, {"probability": {"variance": 0.012244, "average": 0.94428, "min": 0.623799}, "location": {"width": 325, "top": 720, "height": 33, "left": 204}, "words": "变性淋巴瘤激酶; NSCLC=非小细胞肺癌"}, {"probability": {"variance": 0.015369, "average": 0.949275, "min": 0.458634}, "location": {"width": 330, "top": 763, "height": 37, "left": 200}, "words": "研究A8081005中更新的有效性数据"}, {"probability": {"variance": 0.002096, "average": 0.985807, "min": 0.702476}, "location": {"width": 874, "top": 793, "height": 53, "left": 240}, "words": "截至2012年9月,研究A8081005共获得了1033例接受克唑替尼起始剂量250 mg BID治疗的患者的"}, {"probability": {"variance": 9e-06, "average": 0.997285, "min": 0.990026}, "location": {"width": 335, "top": 818, "height": 35, "left": 198}, "words": "有效性数据,其中包括234例中国患者"}, {"probability": {"variance": 0.008516, "average": 0.968658, "min": 0.548696}, "location": {"width": 917, "top": 877, "height": 58, "left": 195}, "words": "表8:研究A8081005中ALK阳性的局部晚期或转移性非小细胞肺癌非中国患者和中国患者的疗效结"}, {"probability": {"variance": 0.001804, "average": 0.971908, "min": 0.901307}, "location": {"width": 149, "top": 906, "height": 31, "left": 194}, "words": "果一客观缓解率"}, {"probability": {"variance": 0, "average": 0.999572, "min": 0.999388}, "location": {"width": 87, "top": 941, "height": 25, "left": 320}, "words": "疗效指标"}, {"probability": {"variance": 1e-05, "average": 0.99714, "min": 0.991123}, "location": {"width": 108, "top": 949, "height": 30, "left": 629}, "words": "非中国患者"}, {"probability": {"variance": 0, "average": 0.999468, "min": 0.998259}, "location": {"width": 85, "top": 960, "height": 26, "left": 927}, "words": "中国患者"}, {"probability": {"variance": 0.000903, "average": 0.976291, "min": 0.91932}, "location": {"width": 92, "top": 985, "height": 22, "left": 635}, "words": "(N=781例"}, {"probability": {"variance": 0.023758, "average": 0.924815, "min": 0.433501}, "location": {"width": 240, "top": 998, "height": 38, "left": 212}, "words": "客观缓解率[%(95%C"}, {"probability": {"variance": 0.000655, "average": 0.978727, "min": 0.916086}, "location": {"width": 93, "top": 993, "height": 23, "left": 920}, "words": "(N=215例)"}, {"probability": {"variance": 0.000127, "average": 0.99298, "min": 0.964614}, "location": {"width": 134, "top": 1014, "height": 24, "left": 557}, "words": "1%(47%,55%"}, {"probability": {"variance": 3e-06, "average": 0.998567, "min": 0.994313}, "location": {"width": 168, "top": 1034, "height": 27, "left": 214}, "words": "中位治疗持续时间"}, {"probability": {"variance": 0.000114, "average": 0.99304, "min": 0.959643}, "location": {"width": 143, "top": 1022, "height": 28, "left": 831}, "words": "43%(36%,50%)"}, {"probability": {"variance": 0.04036, "average": 0.872938, "min": 0.52534}, "location": {"width": 64, "top": 1045, "height": 22, "left": 557}, "words": "6.1周"}, {"probability": {"variance": 0.00135, "average": 0.987481, "min": 0.833705}, "location": {"width": 380, "top": 1064, "height": 37, "left": 211}, "words": "继续接受治疗的患者百分数(%)42.3"}, {"probability": {"variance": 4.2e-05, "average": 0.990085, "min": 0.981516}, "location": {"width": 62, "top": 1097, "height": 23, "left": 201}, "words": "研究A8"}, {"probability": {"variance": 0.003743, "average": 0.959475, "min": 0.824736}, "location": {"width": 195, "top": 1101, "height": 29, "left": 328}, "words": "中有37例患者缓解未评价"}, {"probability": {"variance": 0.016716, "average": 0.950083, "min": 0.400458}, "location": {"width": 648, "top": 1155, "height": 50, "left": 187}, "words": "表9:研究A08105中ALK阳性的局部晚期或转移性非小细胞肺"}, {"probability": {"variance": 1.7e-05, "average": 0.994431, "min": 0.988423}, "location": {"width": 155, "top": 1189, "height": 30, "left": 189}, "words": "果无进展生存期"}, {"probability": {"variance": 5e-06, "average": 0.996934, "min": 0.99278}, "location": {"width": 186, "top": 1178, "height": 36, "left": 920}, "words": "和中国患者的疗效结"}, {"probability": {"variance": 1e-06, "average": 0.999203, "min": 0.997722}, "location": {"width": 88, "top": 1225, "height": 27, "left": 333}, "words": "疗效指标"}, {"probability": {"variance": 0.084777, "average": 0.741072, "min": 0.352709}, "location": {"width": 207, "top": 1219, "height": 46, "left": 656}, "words": "非中国患者"}, {"probability": {"variance": 1e-06, "average": 0.998977, "min": 0.997097}, "location": {"width": 86, "top": 1244, "height": 27, "left": 933}, "words": "中国患者"}, {"probability": {"variance": 4e-06, "average": 0.996978, "min": 0.994214}, "location": {"width": 50, "top": 1269, "height": 22, "left": 704}, "words": "99例"}, {"probability": {"variance": 0.009563, "average": 0.956907, "min": 0.697017}, "location": {"width": 291, "top": 1282, "height": 40, "left": 207}, "words": "无进展生存期,中位数[月(95%"}, {"probability": {"variance": 6.2e-05, "average": 0.988248, "min": 0.978121}, "location": {"width": 97, "top": 1279, "height": 24, "left": 926}, "words": "(N=234例)"}, {"probability": {"variance": 0.008752, "average": 0.933066, "min": 0.756001}, "location": {"width": 76, "top": 1300, "height": 23, "left": 620}, "words": "7.0,9.7)"}, {"probability": {"variance": 0.000679, "average": 0.985853, "min": 0.933738}, "location": {"width": 103, "top": 1315, "height": 33, "left": 204}, "words": "事件数(%"}, {"probability": {"variance": 0.000388, "average": 0.978513, "min": 0.952264}, "location": {"width": 99, "top": 1306, "height": 28, "left": 862}, "words": ".9(5.07.7)"}, {"probability": {"variance": 0.001525, "average": 0.96716, "min": 0.900824}, "location": {"width": 86, "top": 1327, "height": 32, "left": 588}, "words": "422(52.8)"}, {"probability": {"variance": 5.1e-05, "average": 0.994342, "min": 0.97438}, "location": {"width": 222, "top": 1347, "height": 36, "left": 205}, "words": "仍在随访患者百分数(%"}, {"probability": {"variance": 0.000571, "average": 0.973661, "min": 0.931847}, "location": {"width": 50, "top": 1341, "height": 20, "left": 885}, "words": "(47.4)"}, {"probability": {"variance": 0.001356, "average": 0.977769, "min": 0.914005}, "location": {"width": 38, "top": 1363, "height": 21, "left": 588}, "words": "28.4"}, {"probability": {"variance": 0.039786, "average": 0.77886, "min": 0.516544}, "location": {"width": 148, "top": 1373, "height": 54, "left": 844}, "words": "长医姿"}, {"probability": {"variance": 1.4e-05, "average": 0.996883, "min": 0.987156}, "location": {"width": 507, "top": 1414, "height": 41, "left": 222}, "words": "研究A8081005仍在进行中,预计2013年第3季度完成"}, {"probability": {"variance": 3.9e-05, "average": 0.997278, "min": 0.970724}, "location": {"width": 603, "top": 1458, "height": 49, "left": 222}, "words": "尚有3项包括中国患者的随机对照国际多中心临床研究正在进行中"}, {"probability": {"variance": 0, "average": 0.812138, "min": 0.812138}, "location": {"width": 40, "top": 1459, "height": 38, "left": 831}, "words": "男"}, {"probability": {"variance": 0.017796, "average": 0.943923, "min": 0.353444}, "location": {"width": 878, "top": 1503, "height": 63, "left": 219}, "words": "研究A8081007是一项随机(1:1)、对照、开放的ⅢI期研究,在既接受过1次以类为基础的"}], "language": 3}